These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23428303)

  • 1. Medication efficacy: the impact of variability in defining and measuring ADHD and executive functioning.
    Beljan P; Reuter AE; Ganas K; Hoover M
    Appl Neuropsychol Child; 2012; 1(2):152-8. PubMed ID: 23428303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement between Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, and the proposed DSM-V attention deficit hyperactivity disorder diagnostic criteria: an exploratory study.
    Ghanizadeh A
    Compr Psychiatry; 2013 Jan; 54(1):7-10. PubMed ID: 22809622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication.
    Saylor KE; Buermeyer CM; Spencer TJ; Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():23-8. PubMed ID: 12562058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DSM-IV-defined inattention and sluggish cognitive tempo: independent and interactive relations to neuropsychological factors and comorbidity.
    Wåhlstedt C; Bohlin G
    Child Neuropsychol; 2010; 16(4):350-65. PubMed ID: 20574866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The predictive value of DSM-IV criteria in the diagnosis of attention deficit hyperactivity disorder and its cultural differences].
    Cardo E; Bustillo M; Servera M
    Rev Neurol; 2007 Mar; 44 Suppl 2():S19-22. PubMed ID: 17347938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.
    Lahey BB; Pelham WE; Chronis A; Massetti G; Kipp H; Ehrhardt A; Lee SS
    J Child Psychol Psychiatry; 2006 May; 47(5):472-9. PubMed ID: 16671930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.
    Adler LA; Dirks B; Deas PF; Raychaudhuri A; Dauphin MR; Lasser RA; Weisler RH
    J Clin Psychiatry; 2013 Jul; 74(7):694-702. PubMed ID: 23945447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.
    Findling RL; Adeyi B; Dirks B; Babcock T; Scheckner B; Lasser R; DeLeon A; Ginsberg LD
    J Child Adolesc Psychopharmacol; 2013 Feb; 23(1):28-35. PubMed ID: 23410139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do ADHD and executive dysfunctions, measured by the hebrew version of Behavioral Rating Inventory of Executive Functions (BRIEF), completely overlap?
    Linder N; Kroyzer N; Maeir A; Wertman-Elad R; Pollak Y
    Child Neuropsychol; 2010; 16(5):494-502. PubMed ID: 20521184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Population-based diagnostic study to compare the DSM-IV and the Questionnaire for screening Latin American schoolchildren and adolescents for attention deficit hyperactivity disorder].
    Cornelio-Nieto JO; Borbolla-Sala ME; García-Valdovinos S
    Rev Neurol; 2010 Mar; 50 Suppl 3():S119-23. PubMed ID: 20200839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD).
    Toplak ME; Bucciarelli SM; Jain U; Tannock R
    Child Neuropsychol; 2009 Jan; 15(1):53-72. PubMed ID: 18608232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls.
    Geller B; Zimerman B; Williams M; Delbello MP; Bolhofner K; Craney JL; Frazier J; Beringer L; Nickelsburg MJ
    J Child Adolesc Psychopharmacol; 2002; 12(1):11-25. PubMed ID: 12014591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating executive function in schoolchildren with symptoms of attention deficit hyperactivity disorder.
    Vélez-van-Meerbeke A; Zamora IP; Guzmán G; Figueroa B; López Cabra CA; Talero-Gutiérrez C
    Neurologia; 2013; 28(6):348-55. PubMed ID: 22906981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.
    Childress AC; Sallee FR
    CNS Drugs; 2015 Aug; 29(8):683-93. PubMed ID: 26267739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.